CLEARASIL ULTRA RAPID ACTION FACE WASH

Main information

  • Trade name:
  • CLEARASIL ULTRA RAPID ACTION FACE WASH- salicylic acid lotion
  • Composition:
  • Salicylic Acid 2 g in 100 mL
  • Administration route:
  • TOPICAL
  • Prescription type:
  • OTC DRUG
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CLEARASIL ULTRA RAPID ACTION  FACE WASH- salicylic acid lotion
    United States
  • Language:
  • English

Therapeutic information

  • Therapeutic indications:
  • Acne medication for the treatment of acne

Status

  • Source:
  • DailyMed - NLM - National Library of Medicine
  • Authorization status:
  • OTC monograph final
  • Authorization number:
  • 63824-415-67
  • Last update:
  • 02-06-2019

Summary of Product characteristics: dosage, interactions, side effects

CLEARASIL ULTRA RAPID ACTION FACE WASH- salicylic acid lotion

RB Health (US) LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they

comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clearas il

Ultra Rapid Action

Face Wash

Drug Facts

Active ingredient

Salicylic acid 2%

Purpos e

Acne medication

Us e

for the treatment of acne

Warnings

For external use only

When using this product

avoid contact with eyes and mouth. If contact occurs, rinse thoroughly with water.

skin irritation and dryness is more likely to occur if you use another topical acne medication at the

same time. If irritation occurs, only use one topical acne medication at a time.

limit use to the face and neck

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right

away.

Directions

wet face

dispense product into hands and massage gently onto face and neck, avoiding the delicate eye area

cover the entire affected area with a thin layer and rinse thoroughly with warm water one to three

times daily

because excessive drying of the skin may occur, start with one application daily, then gradually

increase to two or three times daily if needed or as directed by a doctor

if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

store in a cool, dry place

do not freeze

Inactive ingredients

®

water, sodium cocoyl isethionate, cetearyl alcohol, glycerin, sodium laureth sulfate, sodium

cocoamphoacetate, cocamidopropyl betaine, sodium hydroxide, acrylates/C10-30 alkyl acrylate

crosspolymer, fragrance, disodium EDTA, Lavendula stoechas extract, Helichrysum italicum extract,

Cistus monspeliensis extract

Ques tions ?

call 1-866-25-CLEAR (1-866-252-5327).

You may also report side effects to this phone number.

Distributed by: Reckitt Benckiser LLC

Parsippany, NJ 07054-0224

Made in France

PRINCIPAL DISPLAY PANEL - 200 mL Tube Label

NEW LOOK

Clearas il

ULTRA

Rapid Action

Daily Face Wash

Salicylic Acid 2% Acne Medication

MAXIMUM STRENGTH

12

HRS

Visibly

clearer skin

in as fast as

12 hours

6.78 FL. OZ. (200 mL)

CLEARASIL ULTRA RAPID ACTION FACE WASH

salicylic acid lotion

Product Information

Product T ype

HUMAN OTC DRUG

Ite m Code (Source )

NDC:6 38 24-415

Route of Administration

TOPICAL

Active Ingredient/Active Moiety

Ingredient Name

Basis of Strength

Stre ng th

Sa licylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ)

Salicylic Acid

2 g in 10 0 mL

Inactive Ingredients

Ingredient Name

Stre ng th

RB Health (US) LLC

wa ter (UNII: 0 59 QF0 KO0 R)

so dium co co yl isethio na te (UNII: 518 XTE8 49 3)

ceto stea ryl a lco ho l (UNII: 2DMT128 M1S)

g lycerin (UNII: PDC6 A3C0 OX)

so dium la ureth-3 sulfa te (UNII: BPV39 0 UAP0 )

so dium co co a mpho a ceta te (UNII: W7Q5E8 76 74)

co ca mido pro pyl beta ine (UNII: 5OCF3O11KX)

so dium hydro xide (UNII: 55X0 4QC32I)

edeta te diso dium (UNII: 7FLD9 1C8 6 K)

Helichrysum ita licum flo wer (UNII: P6 2Y550 X24)

Packag ing

#

Item Code

Package Description

Marketing Start Date

Marketing End Date

1

NDC:6 38 24-415-6 7

20 0 mL in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct

12/0 1/20 13

Marketing Information

Marke ting Cate gory

Application Numbe r or Monograph Citation

Marke ting Start Date

Marke ting End Date

OTC MONOGRAPH FINAL

pa rt333D

12/0 1/20 13

Labeler -

RB Health (US) LLC (081049410)

Revised: 12/2018